Spots Global Cancer Trial Database for favezelimab
Every month we try and update this database with for favezelimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) | NCT03516981 | Advanced Non-Sm... | Pembrolizumab Favezelimab Lenvatinib Quavonlimab | 18 Years - | Merck Sharp & Dohme LLC | |
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) | NCT03516981 | Advanced Non-Sm... | Pembrolizumab Favezelimab Lenvatinib Quavonlimab | 18 Years - | Merck Sharp & Dohme LLC | |
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) | NCT03598608 | Hodgkin Disease Lymphoma, Non-H... Lymphoma, B-Cel... | pembrolizumab Favezelimab | 18 Years - | Merck Sharp & Dohme LLC |